M. Berkovitch et al., CLINICAL RELEVANCE OF THERAPEUTIC DRUG-MONITORING OF DIGOXIN AND GENTAMICIN IN THE SALIVA OF CHILDREN, Therapeutic drug monitoring, 20(3), 1998, pp. 253-256
Digoxin and gentamicin are widely used in pediatric medicine, and ther
apeutic monitoring is mandatory because of their narrow margin of safe
ty and wide interpatient and intrapatient pharmacokinetic variabilitie
s. Saliva sampling may be of potential interest, especially in childre
n, in whom blood sampling is often difficult. In 11 children treated w
ith digoxin for various cardiac conditions, and in 24 children treated
with gentamicin (14 patients were administered gentamicin three times
a day, and 10 once-daily), drugs levels were measured in plasma and s
aliva. There was no correlation between plasma total or free digoxin c
oncentrations and saliva levels, precluding the clinical use of the sa
liva test for digoxin. No correlation was found between plasma gentami
cin concentrations and saliva levels when the drug was administered th
ree times a day; however: good correlation was found when the drug was
administered once-daily (r(2) = 0.89, p < 0.0001). Saliva may be used
as a noninvasive method of measuring gentamicin serum concentrations
to guide dosage adjustments in patients administered the drug once-dai
ly.